These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136 [TBL] [Abstract][Full Text] [Related]
24. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. Shetty N; Wren MW; Coen PG J Hosp Infect; 2011 Jan; 77(1):1-6. PubMed ID: 21145132 [TBL] [Abstract][Full Text] [Related]
25. Lack of value of repeat stool testing for Clostridium difficile toxin. Mohan SS; McDermott BP; Parchuri S; Cunha BA Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786 [TBL] [Abstract][Full Text] [Related]
26. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055 [TBL] [Abstract][Full Text] [Related]
27. [Clostridium difficile infection. The nosocomial aspect]. Bucher A; Nordbø G Tidsskr Nor Laegeforen; 1995 Apr; 115(11):1361-4. PubMed ID: 7770832 [TBL] [Abstract][Full Text] [Related]
29. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275 [TBL] [Abstract][Full Text] [Related]
30. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis. Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients. Shehabi AA; Abu-Ragheb HA; Allaham NA East Mediterr Health J; 2001; 7(4-5):750-5. PubMed ID: 15332775 [TBL] [Abstract][Full Text] [Related]
32. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers. Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466 [TBL] [Abstract][Full Text] [Related]
33. Faecal lactoferrin, capsule endoscopy and Crohn's disease. Is there a three way relationship? A pilot study. Sidhu R; Sanders DS; Wilson P; Foye L; Morley S; McAlindon ME J Gastrointestin Liver Dis; 2010 Sep; 19(3):257-60. PubMed ID: 20922188 [TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703 [TBL] [Abstract][Full Text] [Related]
35. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods]. Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550 [TBL] [Abstract][Full Text] [Related]
36. A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea. Cooper GS; Lederman MM; Salata RA Am J Gastroenterol; 1996 Jan; 91(1):80-4. PubMed ID: 8561149 [TBL] [Abstract][Full Text] [Related]
37. Development and implementation of cost-effective guidelines in the laboratory investigation of diarrhea in a community hospital. Chitkara YK; McCasland KA; Kenefic L Arch Intern Med; 1996 Jul; 156(13):1445-8. PubMed ID: 8678713 [TBL] [Abstract][Full Text] [Related]
38. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. Bishara J; Peled N; Pitlik S; Samra Z J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491 [TBL] [Abstract][Full Text] [Related]
39. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings. Sipponen T; Kärkkäinen P; Savilahti E; Kolho KL; Nuutinen H; Turunen U; Färkkilä M Aliment Pharmacol Ther; 2008 Nov; 28(10):1221-9. PubMed ID: 18752630 [TBL] [Abstract][Full Text] [Related]